GoodRx (GDRX)
(Delayed Data from NSDQ)
$6.91 USD
-0.17 (-2.40%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.90 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
GoodRx Holdings, Inc. (GDRX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.53 | $16.00 | $5.00 | 34.60% |
Price Target
Based on short-term price targets offered by 18 analysts, the average price target for GoodRx Holdings, Inc. comes to $9.53. The forecasts range from a low of $5.00 to a high of $16.00. The average price target represents an increase of 34.6% from the last closing price of $7.08.
Analyst Price Targets (18)
Broker Rating
GoodRx Holdings, Inc. currently has an average brokerage recommendation (ABR) of 1.89 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 1.89 a month ago based on 18 recommendations.
Of the 18 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 55.56% and 5.56% of all recommendations. A month ago, Strong Buy made up 55.56%, while Buy represented 5.56%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 9 | 9 |
Buy | 1 | 1 | 1 | 2 | 2 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.89 | 1.89 | 1.89 | 1.94 | 1.94 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Raymond James | John W Ransom | Moderate Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/9/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/9/2024 | Truist Securities | Jailendra Singh | Hold | Hold |
8/9/2024 | UBS | Kevin Caliendo | Hold | Hold |
8/8/2024 | SVB Securities | Michael Cherny | Strong Buy | Strong Buy |
6/6/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Strong Buy |
5/23/2024 | Not Identified | Not Identified | Hold | Moderate Buy |
4/10/2024 | KeyBanc Capital Markets | Scott Schoenhaus | Strong Buy | Strong Buy |
3/25/2024 | Wells Fargo Securities | Stan Berenshteyn | Hold | Strong Buy |
3/5/2024 | Robert W. Baird & Co. | Vikram Kesavabhotla | Hold | Hold |
3/1/2024 | Goldman Sachs | Eric J Sheridan | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.89 |
ABR (Last week) | 1.89 |
# of Recs in ABR | 18 |
Average Target Price | $9.53 |
LT Growth Rate | 14.50% |
Industry | Medical Services |
Industry Rank by ABR | 152 of 253 |
Current Quarter EPS Est: | 0.09 |
GDRX FAQs
GoodRx Holdings, Inc. (GDRX) currently has an average brokerage recommendation (ABR) of 1.89 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms.
The average price target for GoodRx Holdings, Inc. (GDRX) is $9.53. The current on short-term price targets is based on 5 reports.
The forecasts for GoodRx Holdings, Inc. (GDRX) range from a low of $5 to a high of $16. The average price target represents a increase of $37.92 from the last closing price of $6.91.
The current UPSIDE for GoodRx Holdings, Inc. (GDRX) is 37.92%
Based on short-term price targets offered by 18 analysts, the average price target for GoodRx Holdings, Inc. comes to $9.53. The forecasts range from a low of $5.00 to a high of $16.00. The average price target represents an increase of 34.6% from the last closing price of $7.08.